- Home
- CPRI vs TMDX Comparison
CPRI vs TMDX Comparison
Compare CPRI & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRI
- TMDX
- Stock Information
- Founded
- CPRI 1981
- TMDX 1998
- Country
- CPRI United Kingdom
- TMDX United States
- Employees
- CPRI N/A
- TMDX N/A
- Industry
- CPRI Apparel
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CPRI Consumer Discretionary
- TMDX Health Care
- Exchange
- CPRI Nasdaq
- TMDX Nasdaq
- Market Cap
- CPRI 2.2B
- TMDX 3.9B
- IPO Year
- CPRI 2011
- TMDX 2019
- Fundamental
- Price
- CPRI $21.83
- TMDX $119.81
- Analyst Decision
- CPRI Buy
- TMDX Buy
- Analyst Count
- CPRI 11
- TMDX 11
- Target Price
- CPRI $23.64
- TMDX $125.40
- AVG Volume (30 Days)
- CPRI 2.6M
- TMDX 955.0K
- Earning Date
- CPRI 11-06-2025
- TMDX 10-27-2025
- Dividend Yield
- CPRI N/A
- TMDX N/A
- EPS Growth
- CPRI N/A
- TMDX 2163.11
- EPS
- CPRI N/A
- TMDX 2.02
- Revenue
- CPRI $4,391,000,000.00
- TMDX $531,292,000.00
- Revenue This Year
- CPRI N/A
- TMDX $38.87
- Revenue Next Year
- CPRI $3.87
- TMDX $20.70
- P/E Ratio
- CPRI N/A
- TMDX $59.68
- Revenue Growth
- CPRI N/A
- TMDX 48.09
- 52 Week Low
- CPRI $11.86
- TMDX $55.00
- 52 Week High
- CPRI $43.34
- TMDX $169.29
- Technical
- Relative Strength Index (RSI)
- CPRI 56.30
- TMDX 56.41
- Support Level
- CPRI $20.42
- TMDX $105.00
- Resistance Level
- CPRI $21.96
- TMDX $119.36
- Average True Range (ATR)
- CPRI 0.96
- TMDX 5.23
- MACD
- CPRI -0.03
- TMDX 1.20
- Stochastic Oscillator
- CPRI 82.30
- TMDX 94.05
About CPRI Capri Holdings Limited
Capri Holdings is a marketer, distributor, and retailer of upscale accessories and apparel in the Americas, Europe, and Asia. Michael Kors, Capri's original and largest brand by sales, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. Its products are sold in more than 200 company-operated stores. Capri also owns a third brand, Versace, but has agreed to sell it to Prada. John Idol has served as Capri's CEO since 2003.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.